跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 16,645 条关于
“Arrowhead Therapeutics”
全部
16,645
临床试验
3,570
药物
3,116
机构
1,125
资讯
8,834
去年
Sarepta Therapeutics and Arrowhead Pharmaceuticals Announce RNAi Collaboration to Treat Rare Genetic Diseases
去年
CRISPR Therapeutics' Casgevy Shows Commercial Progress as Gene Therapy Pipeline Advances
8个月前
Arrowhead Pharmaceuticals Raises $700 Million to Advance RNAi Therapeutics Pipeline
上个月
Novel Hypercholesterolemia Drugs Market to Reach USD 42.8 Billion by 2036 as Oral PCSK9 Inhibition and Gene Editing Expand Treatment Options
去年
Arrowhead Pharmaceuticals Advances Two Breakthrough RNAi Therapeutics into Clinical Trials
去年
Arrowhead Pharmaceuticals' FDA Acceptance of Plozasiran NDA Marks Milestone in RNAi Therapeutics
去年
Arrowhead Pharma Focuses on Familial Chylomicronemia Syndrome with Awareness Campaign and Plozasiran Development
去年
Arrowhead Pharmaceuticals CFO Kenneth Myszkowski Sells $893,095 in Stock
19天前
ANGPTL3 Inhibitors Market Poised to Reach $3.48 Billion by 2035 as Pipeline Diversifies Beyond Monoclonal Antibodies
2年前
Arrowhead Pharmaceuticals Advances RNAi Therapies ARO-INHBE and ARO-ALK7 for Obesity Treatment
第 1 页,共 884 页
上一页
下一页